Cardiovascular Abnormalities: Clinical Trials

12 trials for Cardiovascular Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 withdrawn. 12 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Withdrawn 12
Phase 11Withdrawn 1
Phase 31Withdrawn 1

Follow Cardiovascular Abnormalities: new trials by email Literature Review of Cardiovascular Abnormalities trials Research Report on Cardiovascular Abnormalities

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study on Trametinib for Surgical Unruptured AVMs
Trametinib tablet - Arteriovenous Malformations
Phase 2WithdrawnUniversity Health Network, Toronto2024-01-302026-05-22
Addition of Acetaminophen in Standard PDA Management
Intravenous Ibuprofen, Intravenous Ibuprofen + Oral Acetaminophen - Patent Ductus Arteriosus
Phase 2WithdrawnUniversity of Florida2021-04-012021-06-24
Nitric Oxide During Cardiopulmonary Bypass in Neonates to Reduce Risk of Acute Kidney Injury
gases Nitric Oxide (gNO) - Acute Kidney Injury, Congenital Heart Disease
Phase 2 / Phase 3WithdrawnChildren's Hospital Medical Center, Cincinnati2019-10-202020-02-06
Aesculus Hippocastanum L. on Fontan Circulation
Aesculus Hippocastanum / Horse Chestnut, Placebo - Univentricular Heart
Phase 2WithdrawnCasa Espirita Terra de Ismael2017-10-312021-01-28
Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
Thalidomide, Placebo - Gastrointestinal Bleeding of Unknown Origin, Gastrointestinal Vascular Malformation
Phase 2WithdrawnZhizheng Ge2015-12-012016-04-21
Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli
Apixaban, Placebo - Patent Foramen Ovale, Cardiac Implantable Electronic Device
Phase 2WithdrawnMayo Clinic2015-05-012018-11-16
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
MEK162 - Cardiomegaly
Phase 2WithdrawnArray Biopharma, now a wholly owned subsidiary of Pfizer2012-02-012020-10-06
Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)
Timolol 0.5% Gel Forming Solution (GFS), Mupirocin 2% Ointment - Infantile Hemangiomas
Phase 2WithdrawnChildren's Hospital of Philadelphia2011-02-012014-01-17
Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
Indomethacin, Ibuprofen - Patent Ductus Arteriosus
Phase 2WithdrawnShaare Zedek Medical Center2010-06-012012-06-07
Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
Thalidomide, Placebo - Gastrointestinal Hemorrhage, Vascular Malformation
Phase 2WithdrawnShanghai Jiao Tong University School of Medicine2010-03-012016-04-28
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
Iloprost, Placebo - Pulmonary Hypertension, Neonatal Hypoxic Respiratory Failure
Phase 1 / Phase 2WithdrawnSeattle Children's Hospital2009-09-012015-01-19
Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery
Phenoxybenzamine, Standard surgical approach - Congenital Heart Disease
Phase 2WithdrawnVanderbilt University2008-10-012017-05-01

Narrower conditions

Heart Defects, Congenital (3)  ·  Vascular Malformations (3)  ·  Ductus Arteriosus, Patent (2)  ·  Gastrointestinal Hemorrhage (2)  ·  Acute Kidney Injury (1)  ·  Angiodysplasia (1)  ·  Arteriovenous Malformations (1)  ·  Cardiomegaly (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Cognitive Dysfunction (1)  ·  Embolism, Paradoxical (1)  ·  Foramen Ovale, Patent (1)  ·  Hemangioma (1)  ·  Hemangioma, Capillary (1)  ·  Hypertension, Pulmonary (1)

Broader conditions

Cardiovascular Diseases (12)  ·  Congenital Abnormalities (12)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Heart Diseases (8)  ·  Heart Defects, Congenital (5)  ·  Vascular Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Hemorrhage (2)  ·  Pathologic Processes (2)  ·  Aortic Stenosis, Subvalvular (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)

Interventions

Thalidomide (2)  ·  Acetaminophen (1)  ·  Ibuprofen (1)  ·  Iloprost (1)  ·  Indomethacin (1)  ·  Mupirocin (1)  ·  Ointments (1)  ·  Phenoxybenzamine (1)  ·  Timolol (1)  ·  apixaban (1)  ·  binimetinib (1)  ·  horse chestnut seed (1)  ·  trametinib (1)

Sponsors

Array Biopharma, now a wholly owned subsidiary of Pfizer (1)  ·  Casa Espirita Terra de Ismael (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Children's Hospital of Philadelphia (1)  ·  Mayo Clinic (1)  ·  Seattle Children's Hospital (1)  ·  Shaare Zedek Medical Center (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  University Health Network, Toronto (1)  ·  University of Florida (1)  ·  Vanderbilt University (1)  ·  Zhizheng Ge (1)

Countries

United States (4)  ·  China (2)  ·  Brazil (1)  ·  Canada (1)  ·  Israel (1)  ·  United Kingdom (1)

Top investigators

Albert C. Yan, MD (1)  ·  Cathy Hammerman, MD (1)  ·  Christopher DeSimone, MD (1)  ·  David P Bichell, MD (1)  ·  Delphine Yung, MD (1)  ·  Ivan Radovanovic, MD PhD (1)  ·  Patrick McMahon, MD (1)  ·  Paul Friedman, MD (1)  ·  Samuel Asirvatham, MD (1)  ·  Sanket D Shah, MD (1)  ·  Vikash S. Oza, MD (1)  ·  Zhizheng Ge, MD. Ph.D (1)  ·  Zhizheng Ge, Ph.D, MD. (1)

Results publications

PMID 40148035